VitaminaK

Type

Venture Capital

Status

Active

Location

Madrid, Spain

Total investments

19

Average round size

1M

Portfolio companies

15

Rounds per year

1.58

Lead investments

2

Follow on index

0.21

Exits

4

Stages of investment
SeedEarly Stage Venture
Areas of investment
E-CommerceInternetSoftwareFitnessHealth CareSaaSAppsMobile AppsVideo GamesPrice Comparison

Summary

In 2011 was created VitaminaK, which is appeared as VC. The fund was located in Europe if to be more exact in Spain. The leading representative office of defined VC is situated in the Madrid.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the VitaminaK, startups are often financed by Iu00f1aki Arrola, Yago Arbeloa, Wilson Sonsini Goodrich & Rosati. The meaningful sponsors for the fund in investment in the same round are Kibo Ventures, Yago Arbeloa, Civeta Investment. In the next rounds fund is usually obtained by Tsinghua Holdings, Toni Salvatella, Serena.

The fund was created by Gonzalo Castellano, Iu00f1aki Arrola, Rafa Garrido, Rafael Garrido. The overall number of key employees were 3.

Among the most popular fund investment industries, there are Health Care, Photography. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline PromoFarma.com, SinDelantal.Mx, 8fit For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The high activity for fund was in 2014. Comparing to the other companies, this VitaminaK performs on 7 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 1 - 5 millions dollars.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
AI/Big DataB2B/EnterpriseCloud/InfrastructureConsumer/RetailDeveloper Tools Show 5 more
Stage focus
Series ASeries BSeed
Check size
212K — 423K

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
19
Lead investments
2
Exits
4
Rounds per year
1.58
Follow on index
0.21
Investments by industry
  • E-Commerce (7)
  • Health Care (5)
  • Apps (4)
  • Internet (4)
  • Software (3)
  • Show 48 more
Investments by region
  • United States (5)
  • Spain (10)
  • Germany (3)
  • Mexico (1)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
39K
Group Appearance index
0.63
Avg. company exit year
5
Avg. multiplicator
0.04

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
8fit 31 Aug 2015 Fitness, Health Care, Apps, Mobile Apps Seed 2M Berlin, Berlin, Germany
CARTO 10 Sep 2014 SaaS, Enterprise Software, Business Intelligence, Open Source, Location Based Services, Data Visualization, Geospatial Early Stage Venture 8M United States, New York

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.